$2.02
-0.11-5.16%
Last update: Jul 18, 7:53 PM
15 minutes delayed
Comments
Loading...
Indaptus Therapeutics
INDPNASDAQ
Indaptus Therapeutics (NASDAQ:INDP) Stock, Earnings Estimates, EPS, And Revenue
Indaptus Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Aug 12
EPS Estimate
$-0.540
Quarterly Revenue Estimate
–
Annual Revenue
(as of Mar 31)
(as of Mar 31)
–
Analyze the earnings history of Indaptus Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| INDP | Indaptus Therapeutics | -$0.39 | -$0.54 | — | — | $0.00 | — | — | — | 08/12/2024 | Get Alert |
| INDP | Indaptus Therapeutics | -$0.51 | -$0.44 | -$0.45 | -2.27% | $0.00 | — | $0.00 | — | 05/08/2024 | Get Alert |
| INDP | Indaptus Therapeutics | -$0.44 | -$0.54 | -$0.46 | 14.81% | $0.00 | — | $0.00 | — | 03/13/2024 | Get Alert |
| INDP | Indaptus Therapeutics | -$0.42 | -$0.55 | -$0.47 | 14.55% | $0.00 | — | $0.00 | — | 11/06/2023 | Get Alert |
| INDP | Indaptus Therapeutics | -$0.46 | -$0.58 | -$0.39 | 32.76% | $0.00 | — | $0.00 | — | 08/14/2023 | Get Alert |
| INDP | Indaptus Therapeutics | -$0.41 | -$0.59 | -$0.51 | 13.56% | $0.00 | — | $0.00 | — | 05/11/2023 | Get Alert |
| INDP | Indaptus Therapeutics | -$0.22 | -$0.52 | -$0.44 | 15.38% | $0.00 | — | $0.00 | — | 03/17/2023 | Get Alert |
| INDP | Indaptus Therapeutics | -$0.81 | -$0.53 | -$0.42 | 20.75% | $0.00 | — | $0.00 | — | 11/10/2022 | Get Alert |
| INDP | Indaptus Therapeutics | -$5.53 | -$0.48 | -$0.46 | 4.17% | $0.00 | — | $0.00 | — | 08/08/2022 | Get Alert |
| INDP | Indaptus Therapeutics | -$0.31 | -$0.83 | -$0.41 | 50.60% | $0.00 | — | $0.00 | — | 05/12/2022 | Get Alert |
| INDP | Indaptus Therapeutics | -$0.73 | -$0.90 | -$0.22 | 75.56% | $0.00 | — | $0.00 | — | 03/21/2022 | Get Alert |
| INDP | Indaptus Therapeutics | -$0.79 | -$0.60 | -$0.81 | -35.00% | $0.00 | — | $0.00 | — | 11/15/2021 | Get Alert |
| INDP | Indaptus Therapeutics | — | — | -$5.53 | — | — | — | $0.00 | — | 08/16/2021 | Get Alert |
| INDP | Indaptus Therapeutics | — | — | -$0.96 | — | — | — | $0.00 | — | 05/17/2021 | Get Alert |
| INDP | Indaptus Therapeutics | — | — | -$0.73 | — | — | — | $0.00 | — | 03/16/2021 | Get Alert |
| INDP | Indaptus Therapeutics | — | — | -$0.95 | — | — | — | $0.00 | — | 11/05/2020 | Get Alert |
| INDP | Indaptus Therapeutics | — | — | -$0.05 | — | — | — | $0.00 | — | 08/05/2020 | Get Alert |
| INDP | Indaptus Therapeutics | — | — | -$0.08 | — | — | — | $0.00 | — | 05/11/2020 | Get Alert |
| INDP | Indaptus Therapeutics | — | — | -$0.19 | — | — | — | $0.00 | — | 03/13/2020 | Get Alert |
| INDP | Indaptus Therapeutics | — | — | -$0.61 | — | — | — | $0.00 | — | 11/12/2019 | Get Alert |
| INDP | Indaptus Therapeutics | — | — | -$0.30 | — | — | — | $0.00 | — | 08/09/2019 | Get Alert |
Indaptus Therapeutics (INDP) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-05-08 | $-0.45 | $-0.44 | -2.27 % |
| Dec 2023 | 2024-03-13 | $-0.46 | $-0.54 | 14.8 % |
| Sep 2023 | 2023-11-06 | $-0.47 | $-0.55 | 14.5 % |
| Jun 2023 | 2023-08-14 | $-0.39 | $-0.58 | 32.8 % |
Indaptus Therapeutics (INDP) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Indaptus Therapeutics (NASDAQ:INDP) reporting earnings?
Indaptus Therapeutics (INDP) is scheduled to report earnings on August 12, 2024. The last reported earnings were for reported on May 8, 2024 for Q1.
What were the latest earnings per share (EPS) for Indaptus Therapeutics (NASDAQ:INDP)?
The Actual EPS was $-0.45, which missed the estimate of $-0.44.
What were Indaptus Therapeutics’s (NASDAQ:INDP) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.